fda warning letters compounding semaglutide september 2025 A company called Nomida has received an letter for offering for sale injectable weight-loss treatments. None of their offerings are FDA- approved. Nomida is allegedly selling unapproved and Tirzepatide "kits" Diabetes advocacy group discourages use

Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine

You and your Couture provider will discuss your treatment plan, which will likely include gradual dosage increases based on your weekly progress

POMC neurons expressing leptin receptors coordinate metabolic responses to fasting via suppression of leptin levels

CC - central canal

Semaglutide and tirzepatide are not yet PBS listed for obesity, so retatrutide would face the same pathway and timeline challenges

Provider pricing for compounded tirzepatide ranges from around $219 to $700 per month, and the price differences often reflect what is included in the program